Publications by authors named "Teniola Oke"

Claim this Profile
A
Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures.
Laurene S Cheung, Lingling Chen, Teniola F Oke, Thomas B Schaffer, Karim Boudadi

J Immunother Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.
John A Ligon, Woonyoung Choi, Gady Cojocaru, Wei Fu, Emily Han-Chung Hsiue, Teniola F Oke

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures.
Lingling Chen, Teniola Oke, Nicholas Siegel, Gady Cojocaru, Ada J Tam

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy.
Nicolas J Llosa, Brandon Luber, Nicholas Siegel, Anas H Awan, Teniola Oke

Cancer Immunol Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors.
Nicolas J Llosa, Brandon Luber, Ada J Tam, Kellie N Smith, Nicholas Siegel, Teniola Oke

Clin Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, Nicholas Siegel, Hongni Fan, Teniola Oke

J Immunother Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, Nicholas Siegel, Hongni Fan, Teniola Oke

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis